{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:57:24Z","timestamp":1789376244825,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"DOI":"10.1097\/qai.0b013e3181568e3f","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T22:04:46Z","timestamp":1236117886000},"page":"318-322","source":"Crossref","is-referenced-by-count":58,"title":["Higher-Than-Expected Rates of Lactic Acidosis Among Highly Active Antiretroviral Therapy-Treated Women in Botswana"],"prefix":"10.1097","volume":"46","author":[{"given":"C William","family":"Wester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu A","family":"Okezie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Muir","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Bussmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikhulile","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaka","family":"Muzenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Makhema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik van","family":"Widenfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Musonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Novitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tendani","family":"Gaolathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndwapi","family":"Ndwapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Essex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R","family":"Kuritzkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"deGruttola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G","family":"Marlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210131","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral therapy against HIV in resource-limited settings.","volume":"368","author":"Gilks","year":"2006","journal-title":"Lancet"},{"key":"R2-10-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.qai.0000159516.39982.1b","article-title":"Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program.","volume":"40","author":"Idigbe","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-10-20210131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(04)16586-0","article-title":"Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.","volume":"364","author":"Laurent","year":"2004","journal-title":"Lancet"},{"key":"R4-10-20210131","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy.","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet"},{"key":"R5-10-20210131","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/bbrc.1993.1800","article-title":"AZT causes tissue-specific inhibition of mitochondrial bioenergetic function.","volume":"194","author":"Modica-Napolitano","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"R6-10-20210131","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as a common pathway.","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"R7-10-20210131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs.","volume":"1","author":"Lewis","year":"1995","journal-title":"Nat Med"},{"key":"R8-10-20210131","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/339041","article-title":"Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 21 cases and review of the literature.","volume":"34","author":"Falco","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R9-10-20210131","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00002030-200104130-00007","article-title":"Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy.","volume":"15","author":"John","year":"2001","journal-title":"AIDS"},{"key":"R10-10-20210131","first-page":"2891","article-title":"Effects of hyperinsulinemia and hyperglycemia on lactate release and local blood flow in subcutaneous adipose tissue of healthy humans.","volume":"81","author":"Henry","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-10-20210131","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1373\/49.7.1154","article-title":"Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients.","volume":"49","author":"Marceau","year":"2003","journal-title":"Clin Chem"},{"key":"R12-10-20210131","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/095632020501600106","article-title":"Risk factors for hyperlactatemia in HIV- infected patients, Aquitaine Cohort, 1999-2003.","volume":"16","author":"Bonnet","year":"2005","journal-title":"Antivir Chem Chemother"},{"key":"R13-10-20210131","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1086\/324353","article-title":"Hyperlactatemia and antiretroviral therapy: The Swiss HIV Cohort Study.","volume":"33","author":"Boubaker","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R14-10-20210131","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijid.2004.09.010","article-title":"Fatal lactic acidosis associated with tenofovir and abacavir.","volume":"9","author":"Giola","year":"2005","journal-title":"Int J Infect Dis"},{"key":"R15-10-20210131","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1592\/phco.24.11.1089.36138","article-title":"Fatal lactic acidosis associated with coadministration of didanosine and tenofovir disoproxil fumarate.","volume":"24","author":"Guo","year":"2004","journal-title":"Pharmacotherapy"},{"key":"R16-10-20210131","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/108729101753354608","article-title":"Emerging role of riboflavin in the treatment of nucleoside analogue-induced type B lactic acidosis.","volume":"15","author":"Dalton","year":"2001","journal-title":"AIDS Patient Care STDS"},{"key":"R17-10-20210131","first-page":"387","article-title":"Riboflavin treatment of antiretroviral induced lactic acidosis and hepatic steatosis.","volume":"65","author":"Posteraro","year":"2001","journal-title":"Conn Med"},{"key":"R18-10-20210131","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1258\/0956462011923228","article-title":"Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART.","volume":"12","author":"Arici","year":"2001","journal-title":"Int J STD AIDS"},{"key":"R19-10-20210131","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1097\/00002030-200012010-00027","article-title":"Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis.","volume":"14","author":"Brinkman","year":"2000","journal-title":"AIDS"},{"key":"R25-10-20210131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/44.1.137","article-title":"Acute pancreatitis with severe lactic acidosis in an HIV-infected patient on didanosine therapy.","volume":"44","author":"Allaouchiche","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"R26-10-20210131","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/45.3.411","article-title":"Acute pancreatitis associated with severe lactic acidosis in human immunodeficiency virus-infected patients receiving triple therapy.","volume":"45","author":"Frippiat","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"R28-10-20210131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.","volume":"354","author":"Gallant","year":"2006","journal-title":"N Engl J Med"},{"key":"R29-10-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200711010-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:20:08Z","timestamp":1618039208000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200711010-00010"}},"subtitle":["Preliminary Results from a Large Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181568e3f","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11,1]]}}}